PubMed Health⌕ Search

PubMed · 12928805

[Corticophobia in asthma].

Abstract

BACKGROUND: Steroid phobia is regarded as a common phenomenon in the management of asthma, eventually contributing to poor compliance in these patients. The aim of this survey was to examine asthma patients (adults and children with their parents) and general practitioners (GPs) if inhaled corticosteroids are a matter of concern. METHODS: The physicians were asked what they assume, their patients would answer. To accomplish this, 407 physicians (202 GPs without subspecialty, 103 internists, 102 pediatricians) and 346 patients (245 adults, 101 children, 109 parents) were questioned using a structured questionnaire. RESULTS: In contrast to patients, physicians rated inhaled corticosteroids as the medication the patients wanted primarily to get rid of (in parenthesis physician answers): adult asthmatics 17% (55%), children 19%, parents 26% (55%). The answer "side effects" to the question "What do you dislike most in your asthma medication?" was given as follows: physicians 58%, adult asthmatics 42%, children 10%, parents 14%, and pediatricians 46%. Major lack of knowledge regarding the use and function of asthma medication was excluded in these patients as well as in the children's parents. The request for further information regarding their disease varied: adult asthmatics 57%, children 66%, parents 90%. CONCLUSION: Our survey indicates that physicians may overestimate patients' concern to use inhaled corticosteroids in asthma therapy. For patients rejecting corticosteroid therapy other antiinflammatory treatment options must be considered as an alternative individually.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Adrian Gillissen, Josef Lecheler. 2003-08-15. [Corticophobia in asthma].. https://doi.org/10.1007/s00063-003-1262-0

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Concurrent carbogen and radiation therapy in children with high-risk brainstem gliomas.

In an attempt to improve local control, we assessed the feasibility of the addition of 4 min of carbogen inhalation (as a radiosensitizer) to daily fractionated radiotherapy in pediatric patients with high grade and/or diffuse brainstem gliomas. Ten patients inhaled carbogen for >90% of the radiation treatments. Median survival time from start of therapy was 0.80 years. Carbogen inhalation did not appear to improve the dismal prognosis.

Administration, Inhalation↗

2. Advances in pharmacotherapy for COPD.

Chronic obstructive pulmonary disease (COPD) is the most common chronic lung disease in the world. In 1999, COPD ranked sixth among the most common causes of death and twelfth as a worldwide burden of disease. It has been estimated that by the year 2020 COPD will be the third leading cause of death and fifth as a worldwide burden of disease. Thus, COPD is a major medical problem and there is evidence that it is increasing throughout the world. Despite recognition of COPD as an important international health problem, COPD has been neglected among common diseases, with little investment in research on its underlying cellular and molecular mechanisms. Recently, global and Japanese guidelines for COPD have been published. These guidelines seem to be useful to improve the underdiagnosis and undertreatment of COPD. In this review, I describe briefly the current recommendation for pharmacological therapy of stable COPD according to the global and Japanese guidelines for COPD.

Administration, Inhalation↗